64Cu-LNTH-1363S
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 64Cu-LNTH-1363S, covering 2025-08-12 to 2025-08-12. Get the full timeline:
Most recent: Clinical Trial Update: 64Cu-LNTH-1363S in Patients With Sarcoma or Gastrointestinal Tract Cancer [Phase 1, Phase 2]